4th Quarter - Report

THE GIBSON GROUP, LLC for ENDO PHARMACEUTICALS INC.

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Government Issues GOV

H.R. 3010 - Regulatory Accountability Act of 2011

LobbyistCovered position, as disclosed
JOSEPH H GIBSON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3010 (112th)

Taxation/Internal Revenue Code TAX

H.R. 2632 - Life Sciences Jobs and Investment Act of 2011

LobbyistCovered position, as disclosed
JOSEPH H GIBSON New —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2632 (112th)

Health Issues HCR

S. 319 - Pharmaceutical Market Access and Drug Safety Act of 2011 Issues relating to bioequivalence and related administrative procedures Issues relating to DEA quotas for controlled substances

LobbyistCovered position, as disclosed
JOSEPH H GIBSON Counsel, House Judiciary Comm. '95-'97

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 319 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.